Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
2003 1
2008 1
2009 1
2010 1
2011 1
2012 1
2014 2
2015 4
2016 2
2017 3
2018 1
2019 1
2021 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Clinical value of serum biomarkers, squamous cell carcinoma antigen and apolipoprotein C-II in follow-up of patients with locally advanced cervical squamous cell carcinoma treated with radiation: A multicenter prospective cohort study.
Harima Y, Ariga T, Kaneyasu Y, Ikushima H, Tokumaru S, Shimamoto S, Takahashi T, Ii N, Tsujino K, Saito AI, Ushijima H, Toita T, Ohno T. Harima Y, et al. PLoS One. 2021 Nov 2;16(11):e0259235. doi: 10.1371/journal.pone.0259235. eCollection 2021. PLoS One. 2021. PMID: 34727105 Free PMC article.
There are currently no reliable, established serum biomarkers to predict the prognosis of radiotherapy for advanced cervical cancer. ...Pre- and posttreatment serum SCC-Ag and pretreatment serum ApoC-II levels may be important biomarkers to predict survival outcomes …
There are currently no reliable, established serum biomarkers to predict the prognosis of radiotherapy for advanced cervical cancer. …
Clinical Significance of Serum SCC Levels Before Treatment for Locally Advanced Cervical Squamous Cell Carcinoma.
Yamaoka Y, Tamura S, Yamanoi K, Taki M, Murakami R, Yamaguchi K, Hamanishi J, Mandai M. Yamaoka Y, et al. Anticancer Res. 2024 May;44(5):2009-2019. doi: 10.21873/anticanres.17004. Anticancer Res. 2024. PMID: 38677756
BACKGROUND/AIM: Although serum squamous cell carcinoma (SCC) antigen values are known to be useful in predicting the prognosis of cervical SCC, they have only been examined in a cursory manner. This study aimed to meticulously investigate the clinical significance of serum …
BACKGROUND/AIM: Although serum squamous cell carcinoma (SCC) antigen values are known to be useful in predicting the prognosis of cer …
Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma of cervix after definitive radiotherapy or concurrent chemoradiotherapy.
Hu K, Wang W, Liu X, Meng Q, Zhang F. Hu K, et al. Radiat Oncol. 2018 Dec 17;13(1):249. doi: 10.1186/s13014-018-1197-5. Radiat Oncol. 2018. PMID: 30558636 Free PMC article.
BACKGROUND: Concurrent chemoradiotherapy (CCRT) is effective in the treatment of locally advanced cervical squamous cell carcinoma (SCC). However, whether treatment outcomes of cervical adenocarcinoma are equivalent to SCC after CCRT has been a …
BACKGROUND: Concurrent chemoradiotherapy (CCRT) is effective in the treatment of locally advanced cervical squamous
Neoadjuvant chemotherapy does not improve the prognosis and lymph node metastasis rate of locally advanced cervical squamous cell carcinoma: A retrospective cohort study in China.
Yan W, Si L, Ding Y, Qiu S, Zhang Q, Liu L. Yan W, et al. Medicine (Baltimore). 2019 Sep;98(39):e17234. doi: 10.1097/MD.0000000000017234. Medicine (Baltimore). 2019. PMID: 31574835 Free PMC article.
The adverse reactions in the NACT group were mainly hematologic toxic reactions, but were tolerated. No grade III adverse reactions were observed. NACT did not significantly affect the PFS (P = .453) and OS (P = .933) between the 2 groups. ...
The adverse reactions in the NACT group were mainly hematologic toxic reactions, but were tolerated. No grade III adverse reactions were …
Genetic alterations of PIK3CA and tumor response in patients with locally advanced cervical squamous cell carcinoma treated with cisplatin-based concurrent chemoradiotherapy.
Wang J, Chai YL, Wang T, Liu JH, Dai PG, Liu Z. Wang J, et al. Exp Mol Pathol. 2015 Jun;98(3):407-10. doi: 10.1016/j.yexmp.2015.03.014. Epub 2015 Mar 13. Exp Mol Pathol. 2015. PMID: 25773678
OBJECTIVE: The objective of this study was to investigate the predictive value of common genetic alterations of PI3K/AKT/mTOR and Ras/Raf/MAPK pathways in patients with locally advanced cervical squamous cell carcinoma (LACSCC) treated wi …
OBJECTIVE: The objective of this study was to investigate the predictive value of common genetic alterations of PI3K/AKT/mTOR and Ras …
Expression of ERCC1 and TUBB3 in locally advanced cervical squamous cell cancer and its correlation with different therapeutic regimens.
Zwenger AO, Grosman G, Iturbe J, Leone J, Vallejo CT, Leone JP, Verdera PP, Pérez JE, Leone BA. Zwenger AO, et al. Int J Biol Markers. 2015 Jul 22;30(3):e301-14. doi: 10.5301/jbm.5000161. Int J Biol Markers. 2015. PMID: 26165688 Free article.
We assessed the role of ERCC1 and TUBB3 expressions as predictive and prognostic factors in locally advanced cervical squamous cell carcinoma (LACSCC) patients treated with different neoadjuvant regimens. ...CONCLUSIONS: ERCC1 expression …
We assessed the role of ERCC1 and TUBB3 expressions as predictive and prognostic factors in locally advanced cervical
Aberrant expression of osteopontin and E-cadherin indicates radiation resistance and poor prognosis for patients with cervical carcinoma.
Huang X, Qian Y, Wu H, Xie X, Zhou Q, Wang Y, Kuang W, Shen L, Li K, Su J, Shen L, Chen X. Huang X, et al. J Histochem Cytochem. 2015 Feb;63(2):88-98. doi: 10.1369/0022155414561329. Epub 2014 Nov 7. J Histochem Cytochem. 2015. PMID: 25380749 Free PMC article.
Consequently, we explored if E-cadherin (a marker of epithelial-mesenchymal transition) and osteopontin could predict radioresistance in patients with locally advanced cervical squamous cell carcinoma (LACSCC). ...
Consequently, we explored if E-cadherin (a marker of epithelial-mesenchymal transition) and osteopontin could predict radioresistance …
High Expression of SOX2 and OCT4 Indicates Radiation Resistance and an Independent Negative Prognosis in Cervical Squamous Cell Carcinoma.
Shen L, Huang X, Xie X, Su J, Yuan J, Chen X. Shen L, et al. J Histochem Cytochem. 2014 Jul;62(7):499-509. doi: 10.1369/0022155414532654. Epub 2014 Apr 7. J Histochem Cytochem. 2014. PMID: 24710660 Free PMC article.
Consequently, we aimed to explore if the stem cell biomarkers SOX2 and OCT4 protein could be used to predict radioresistance in patients with locally advanced cervical squamous cell carcinoma (LACSCC). ...Our study suggests that the expre …
Consequently, we aimed to explore if the stem cell biomarkers SOX2 and OCT4 protein could be used to predict radioresistance in patie …
Overexpression of the oncostatin M receptor in cervical squamous cell carcinoma cells is associated with a pro-angiogenic phenotype and increased cell motility and invasiveness.
Winder DM, Chattopadhyay A, Muralidhar B, Bauer J, English WR, Zhang X, Karagavriilidou K, Roberts I, Pett MR, Murphy G, Coleman N. Winder DM, et al. J Pathol. 2011 Nov;225(3):448-62. doi: 10.1002/path.2968. Epub 2011 Sep 26. J Pathol. 2011. PMID: 21952923
Oncostatin M receptor (OSMR) shows frequent copy number gain and overexpression in advanced cervical squamous cell carcinoma (SCC). We used cell-based in vitro assays, RNA interference, and integrative gene expression profiling to investigate th …
Oncostatin M receptor (OSMR) shows frequent copy number gain and overexpression in advanced cervical squamous cell
The Prognosis and Risk Stratification Based on Pelvic Lymph Node Characteristics in Patients With Locally Advanced Cervical Squamous Cell Carcinoma Treated With Concurrent Chemoradiotherapy.
Li X, Wei LC, Zhang Y, Zhao LN, Li WW, Ping LJ, Dang YZ, Hu J, Shi M. Li X, et al. Int J Gynecol Cancer. 2016 Oct;26(8):1472-9. doi: 10.1097/IGC.0000000000000778. Int J Gynecol Cancer. 2016. PMID: 27400321
BACKGROUND: The purpose of this study is to determine the prognostic significance of pelvic lymph node (PLN) characteristics and perform risk stratification in patients undergoing concurrent chemoradiotherapy for locally advanced cervical squamous cell
BACKGROUND: The purpose of this study is to determine the prognostic significance of pelvic lymph node (PLN) characteristics and perform ris …
20 results